ImmuCell Corporation Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
ImmuCell Corporation (ICCC) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$215.98 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-30
- ImmuCell Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$215.98K.
- ImmuCell Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$450.78K.
- ImmuCell Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$1.21M.
- ImmuCell Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$522.09K.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$215.98K 10-K · filed 2026-03-30 | |
| 2024-12-31 | -$450.78K 10-K · filed 2026-03-30 | |
| 2023-12-31 | -$1.21M 10-K · filed 2025-03-28 | |
| 2022-12-31 | -$522.09K 10-K · filed 2024-04-01 | |
| 2021-12-31 | -$14.52K 10-K · filed 2023-03-29 | $14.52K 10-K · filed 2022-03-30 |
| 2020-12-31 | $216.77K 10-K · filed 2022-03-30 | |
| 2019-12-31 | -$266.16K 10-K · filed 2020-03-27 | |
| 2018-12-31 | -$390.61K 10-K · filed 2020-03-27 | |
| 2017-12-31 | -$149.08K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |